Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Dec;4(6):999-1004.
doi: 10.3892/etm.2012.727. Epub 2012 Sep 27.

High overexpression of fatty acid synthase is associated with poor survival in Chinese patients with gastric carcinoma

Wenmin Hou  1 , Maogui Fei, Xia Qin, Xuehua Zhu, Joel Greshock, Ping Liu, Yuanfeng Zhou, Hui Wang, Bang-Ce Ye, Crystal Ying Qin
Affiliations

High overexpression of fatty acid synthase is associated with poor survival in Chinese patients with gastric carcinoma

Wenmin Hou et al. Exp Ther Med. 2012 Dec.

Abstract

Fatty acid synthase (FAS) is the key enzyme regulating de novo biosynthesis of fatty acids. FAS overexpression has been found in many types of tumors and is associated with poor survival. However, the expression of FAS and its relationship with prognosis in Chinese patients with gastric carcinoma are still unknown. Therefore, in this study, we examined the expression of FAS using tissue microarrays and determined its correlation with clinicopathological characteristics and prognosis of gastric carcinoma in Chinese patients. FAS overexpression was graded as S (T/A) <1, ≥1 to <2, ≥2 to <3 or ≥3 in 35 (38.9%), 20 (22.2%), 9 (10%) and 26 (28.9%) patients, respectively. High FAS overexpression [S (T/A) ≥3] was significantly correlated with poor prognosis (log-rank test, P= 0.0078) and with decreased 3-year survival rate (χ(2) test, P=0.0023). FAS overexpression was not significantly associated with other clinicopathological characteristics. In conclusion, our results suggest that FAS expression might be a potential prognostic marker for gastric carcinoma in Chinese patients.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Immunohistochemical expression of FAS in gastric carcinomas. (A) Representative tissue microarray. The odd and even lines represent tumor and adjacent normal tissue samples, respectively. (B) Representative cases of immunohistochemical expression of FAS for S (T/A) ≥1 to <2, S (T/A) ≥2 to <3 and S (T/A) ≥3. S (T/A) = immunohistochemistry score (tumor)/immunohistochemistry score (adjacent tissue). Immunohistochemistry score = staining intensity x percent of FAS-positive cells. Staining intensity was scored as 0, negative; 1, weak; 2, moderate; and 3, high.
Figure 2
Figure 2
(A) Scatter plot showing the distribution of the immunohistochemical (IHC) score for FAS expression in gastric tumor tissues and adjacent normal tissues. The mean IHC scores for FAS expression in tumors and adjacent tissues are 1.065±0.099 and 0.7981±0.074, respectively. The P-value was determined by an unpaired test. (B) Distribution of FAS expression defined as S (T/A). Overall, 38.9% (35/90), 22.2% (20/90), 10% (9/90) and 28.9% (26/90) of the carcinoma tissue specimens were classified as S (T/A) ≥0 to <1, S (T/A) ≥1 to <2, S (T/A) ≥2 to <3 and S (T/A) ≥3, respectively.
Figure 3
Figure 3
The highest level of FAS overexpression is associated with poor survival of patients with gastric carcinoma. (A–C) show survival curves for patients with carcinomas classified as S (T/A) ≥1, ≥2 and ≥3, respectively. FAS overexpression corresponding to S (T/A) ≥1 or ≥2 was not associated with survival. Patients with S (T/A) ≥3 had significantly worse overall survival compared with all other patients (log-rank test, P=0.0078).
See this image and copyright information in PMC

References

    1. Kuhajda FP. Fatty-acid synthase and human cancer: new perspectives on its role in tumor biology. Nutrition. 2000;16:202–208. - PubMed
    1. Takahiro T, Shinichi K, Toshimitsu S. Expression of fatty acid synthase as a prognostic indicator in soft tissue sarcomas. Clin Cancer Res. 2003;9:2204–2212. - PubMed
    1. Menendez JA, Lupu R. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat Rev Cancer. 2007;7:763–777. - PubMed
    1. Van de Sande T, De SE, Heyns W, Verhoeven G, Swinnen JV. Role of the phosphatidylinositol 3′-kinase/PTEN/Akt kinase pathway in the overexpression of fatty acid synthase in LNCaP prostate cancer cells. Cancer Res. 2002;62:642–646. - PubMed
    1. Escot C, Joyeux C, Mathieu M, Maudelonde T, Pages A, Rochefort H, Chalbos D. Regulation of fatty acid synthetase ribonucleic acid in the human endometrium during the menstrual cycle. J Clin Endocrinol Metab. 1990;70:1319–1324. - PubMed